Sep 2026· Annals of Child Neurology· 0 citations· 23 references
TL;DR
SEEG appears to be an effective, safe, and minimally invasive evaluation modality for pediatric DRE, associated with favorable seizure outcomes even in complex, deep-seated, multilobar, or non-lesional cases, supporting its role as a valuable alternative to subdural grid-based intracranial monitoring.
Abstract
Purpose: This study evaluated surgical outcomes after stereoelectroencephalography (SEE-G)-guided epilepsy surgery in pediatric patients with drug-resistant epilepsy (DRE) compared with outcomes after conventional subdural grid evaluation. Methods: We retrospectively analyzed pediatric patients with DRE who underwent resective epilepsy surgery at a single center from 2015 to 2023 and had at least 1 year of follow-up. The cohort comprised 36 patients evaluated with SEEG and 65 evaluated with subdural grids. We compared clinical characteristics, surgical outcomes, and procedure-related complications between groups. Results: The SEEG group included a higher proportion of patients with prior epilepsy surgery (25.0% vs. 13.8%). Despite this greater clinical complexity, postoperative seizure outcomes were significantly more favorable in the SEEG group: 75.0% achieved Engel class I (vs. 46.2% in the grid group; P=0.003) and 69.4% achieved International League Against Epilepsy class 1 (vs. 44.6%; P <0.001). SEEG was frequently used for reoperations, deep-seated lesions, and bilateral or multilobar cases. The duration of invasive monitoring was significantly shorter in the SEEG group (median 5 days vs. 7 days; P <0.001). Conclusion: SEEG appears to be an effective, safe, and minimally invasive evaluation modality for pediatric DRE. It was associated with favorable seizure outcomes even in complex, deep-seated, multilobar, or non-lesional cases, supporting its role as a valuable alternative to subdural grid-based intracranial monitoring.
OBJECTIVE
This study was undertaken to present more than 2 decades of experience with stereoelectroencephalography (SEEG)-guided radiofrequency thermocoagulation (RF-TC) in focal drug-resistant epilepsy and to identify clinical, electrophysiological, and procedural predictors of treatment response.
METHODS
We retrosp...
Francisco Spessatto Pesente, M. Sampaio, H. Catenoix et al.· Epilepsia· 0 citations
This study expands the limited literature on insular neuromodulation by demonstrating effectiveness of RNS and CSS, suggesting potential benefit from combined thalamocortical targeting, and defining parasagittal trajectories as a surgical approach for optimal lead proximity.
Raunak Singh, N. Gregg, K. Starnes et al.· Epilepsia· 0 citations
Epilepsy is a neurological disorder affecting over 50 million people worldwide, with a global incidence of 7.6 per 1,000 individuals. Mesial temporal lobe epilepsy (MTLE) is characterized by recurrent, unprovoked seizures originating in the temporal lobe. The standard surgical treatment is anterior temporal lobectomy;...
V. A. García-García, Marco Vinicio Ramírez-Sánchez, R. García-Romero et al.· Chinese Neurosurgical Journa...· 0 citations
MRgLITT is a promising minimally invasive option for carefully selected patients with eCCMs and shorter duration of epilepsy before treatment was associated with seizure freedom, and concordant presurgical evaluation may predict favorable outcome.
Nathan A. Shlobin, Adrian E. Jimenez, W. Yevudza et al.· Operative Neurosurgery· 0 citations
OBJECTIVE
This study aimed to assess the quality of life and cognitive well-being of patients operated on for drug resistant epilepsy (DRE) in Cameroon.
METHODS
We conducted a single-center, prospective single-arm cohort of 31 patients with DRE who underwent epilepsy surgery between January 2018 and March 2024. Prima...
Ghislain Guea Ngbwa, Oumarou Haman Nassourou, Evina Bekolo Nga et al.· World Neurosurgery· 0 citations
It is found that factors such as fewer anti-seizure medications and complete resection of the lesion were associated with a favorable outcome on multivariable analysis and should not per se exclude patients with MCD from undergoing epilepsy surgery.
M. B. Rao, Ajinkya Rewatkar, A. Asranna et al.· Neurology India· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.